Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nagaraj, Manickam"'
Autor:
R M Anjana, Nagaraj Manickam, Viswanathan Mohan, Isaivani Jayachandran, Balachandar Venkatesan, Muthuswamy Balasubramanyam, Saravanakumar Sundararajan, S C Subramanian
Publikováno v:
Journal of Endocrinological Investigation. 44:1395-1405
We earlier reported that Sestrin2 regulates monocyte activation and atherogenic events through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions. However, the statuses of Sestrins in diabetes and dyslipidemia are not known. We report her
Autor:
Anandakumar Amutha, Ranjit Mohan Anjana, Coimbatore Subramanian Shanthi Rani, Harish Ranjani, Nagaraj Manickam, Saravanan Jebarani, Mohan Deepa, Rajendra Pradeepa, Vasudevan Sudha, Subramani Poongothai, Somasundaram Jaya Parvathi, Venkatesan Radha, Muthuswamy Balasubramanyam, Ranjit Unnikrishnan, Ulagamathesan Venkatesan, Viswanathan Mohan
Publikováno v:
Diabetes Technology & Therapeutics
Aim: To evaluate the effects of a prolonged lockdown due to Coronavirus (COVID-19) on the adoption of newer technologies and changes in glycemic control on patients with type 2 diabetes (T2D) in India. Methods: The study population included a random
Autor:
Muthuswamy Balasubramanyam, Viswanathan Mohan, Chandrakumar Sathishkumar, Nagaraj Manickam, K. Gokulakrishnan, Gautam Kumar Pandey, Prabhu Durairaj, Saravanakumar Sundararajan
Publikováno v:
Molecular biology reports. 48(5)
A role of Retinol Binding Protein-4 (RBP4) in insulin resistance is widely studied. However, there is paucity of information on its receptor viz., Stimulated by Retinoic Acid-6 (STRA6) with insulin resistance. To address this, we investigated the reg
Autor:
Muthuswamy Balasubramanyam, Saravanakumar Venkatesan, Isaivani Jayachandran, Saravanakumar Sundararajan, Viswanathan Mohan, Nagaraj Manickam, Sairaj Paadukaana
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-17 (2020)
Scientific Reports
Scientific Reports
We previously reported that the circulatory level of Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, was increased in diabetic kidney disease patients. However, the mechanism and the role of ADMA in d
Autor:
Viswanathan Mohan, Balachandar Venkatesan, Saravanakumar Venkatesan, Isaivani Jayachandran, Saravanakumar Sundararajan, Muthuswamy Balasubramanyam, Nagaraj Manickam
Publikováno v:
Indian Journal of Inflammation Research. 4
Diabetes is a group of metabolic disorders characterized by hyperglycemia and associated chronic complications including cardiovascular diseases. Hyperglycemia induces various stress conditions including oxidative /endoplasmic reticulum (ER) stress,
Autor:
Viswanathan Mohan, Prabhakar Sripadi, Nagarjuna Chary Ragi, Nivedita Bhattacharya, Paramasivam Prabu, Thyparambil Aravindakshan Pramodkumar, Avinash D. Ghanate, Gokulakrishnan Kuppan, Dharmeshkumar S. Parmar, Gautam Kumar Pandey, Nagaraj Manickam, Shanthini Kannan, Venkateswarlu Panchagnula, Sangeetha Vadivel
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Altered circulatory asymmetric and symmetric dimethylarginines have been independently reported in patients with end-stage renal failure suggesting their potential role as mediators and early biomarkers of nephropathy. These alterations can also be r
Autor:
Saravanakumar Sundararajan, Isaivani Jayachandran, Balachandar Venkatesan, Viswanathan Mohan, Muthuswamy Balasubramanyam, Nagaraj Manickam
Publikováno v:
Journal of cellular biochemistry.
The vicious cycle between hyperinsulinemia and insulin resistance results in the progression of atherosclerosis in the vessel wall. The complex interaction between hyperglycemia and lipoprotein abnormalities promotes the development of atherogenesis.
Autor:
Prabu Paramasivam, Saravanakumar Sundararajan, Nagaraj Manickam, Muthuswamy Balasubramanyam, Shanthirani C. Subramanian, Balachandar Venkatesan, Isaivani Jayachandran, Viswanathan Mohan
Publikováno v:
Clinical biochemistry. 50(15)
Aim Asymmetric dimethylarginine (ADMA) is involved in the regulation of nitric oxide synthesis and in the maintenance of vascular tone and structure. But the role and status of ADMA in diabetes induced kidney injury is not clear. Hence this study is
Autor:
Anjana, Ranjit Mohan, Pradeepa, Rajendra, Deepa, Mohan, Jebarani, Saravanan, Venkatesan, Ulagamathesan, Parvathi, Somasundaram Jaya, Balasubramanyam, Muthuswamy, Radha, Venkatesan, Poongothai, Subramani, Sudha, Vasudevan, Shanthi Rani, Coimbatore Subramanian, Ranjani, Harish, Amutha, Anandakumar, Manickam, Nagaraj, Unnikrishnan, Ranjit, Mohan, Viswanathan, Rani, C S Shanthi, Harish, Ranjani, Nagaraj, Manickam, Ranjit, Unnikrishnan
Publikováno v:
Diabetes Technology & Therapeutics; Jul2020, Vol. 22 Issue 7, p527-534, 8p
Autor:
Abirami Narayanasamy, Madhulika Dixit, Regin Bhaskaran, Nagaraj Manickam, Anand Chakroborty, Shiny Abhijit, Viswanathan Mohan, Muthuswamy Balasubramanyam
Publikováno v:
Molecular and Cellular Biochemistry. 373:95-105
Atherosclerosis is one of the major complications of diabetes and involves endothelial dysfunction, matrix alteration, and most importantly migration and proliferation of vascular smooth muscle cells (VSMCs). Although hyperglycemia and hyperinsulinem